Company Premier Biomedical, Inc. Other OTC
Equities
BIEI
US74048K2033
Specialty Chemicals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gabe Vlad
DFI | Director of Finance/CFO | - | - |
William Tynan
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | - | - | |
Carl Eller
SAM | Sales & Marketing | - | 15/11/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 133,780 | 0 | 0 | 99.00 % |
Stock B | 1 | 1,098,879,075 | 1,087,891,076 ( 99.00 %) | 0 | |
Stock C | 0 | 2,000,000 | 0 | 0 |
Company contact information
Premier Biomedical, Inc.
2409 Sycamore Drive
37921, Knoxville
+724 633 7033
http://www.premierbiomedical.comSales per Business
1st Jan change | Capi. | |
---|---|---|
+3.62% | 49.8B | |
+21.50% | 42.65B | |
+25.66% | 26.61B | |
+10.43% | 19.29B | |
-1.61% | 16.7B | |
+5.88% | 15.94B | |
-11.69% | 15B | |
-29.11% | 14.43B | |
-17.88% | 14.12B |